|
|
||||||||
1 modulates the expression of
vascular endothelial growth factor by osteoblasts
1 Department of Surgery, University of Connecticut, Farmington, Connecticut 06032; 2 Laboratory of Developmental Biology and Repair, Department of Surgery, New York University School of Medicine, New York, New York 10016; and 3 Department of Cardiology, Kyushu University School of Medicine, Fukuoka 812, Japan
Angiogenesis is essential to both normal and pathological bone
physiology. Vascular endothelial growth factor (VEGF) has been implicated in angiogenesis, whereas transforming growth factor-
1 (TGF-
1) modulates bone differentiation, matrix
formation, and cytokine expression. The purpose of this study was to
investigate the relationship between TGF-
1 and VEGF expression in
osteoblasts and osteoblast-like cells. Northern blot analysis revealed
an early peak of VEGF mRNA (6-fold at 3 h) in fetal rat calvarial cells
and MC3T3-E1 osteoblast-like cells after stimulation with TGF-
1 (2.5 ng/ml). The stability of VEGF mRNA in MC3T3-E1 cells was not increased
after TGF-
1 treatment. Actinomycin D inhibited the TGF-
1-induced
peak in VEGF mRNA, whereas cycloheximide did not. Blockade of TGF-
1
signal transduction via a dominant-negative receptor II adenovirus
significantly decreased TGF-
1 induction of VEGF mRNA. Additionally,
TGF-
1 induced a dose-dependent increase in VEGF protein expression
by MC3T3-E1 cells (P < 0.01).
Dexamethasone similarly inhibited VEGF protein expression. Both
TGF-
1 mRNA and VEGF mRNA were concurrently present in rat membranous
bone, and both followed similar patterns of expression during rat
mandibular fracture healing (mRNA and protein). In summary,
TGF-
1-induced VEGF expression by osteoblasts and osteoblast-like
cells is a dose-dependent event that may be intimately related to bone
development and fracture healing.
angiogenesis; bone; fracture
This article has been cited by other articles:
![]() |
N. W. Clavin, T. Avraham, J. Fernandez, S. V. Daluvoy, M. A. Soares, A. Chaudhry, and B. J. Mehrara TGF-{beta}1 is a negative regulator of lymphatic regeneration during wound repair Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2113 - H2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benckert, S. Jonas, T. Cramer, Z. von Marschall, G. Schafer, M. Peters, K. Wagner, C. Radke, B. Wiedenmann, P. Neuhaus, et al. Transforming Growth Factor {beta}1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells Cancer Res., March 1, 2003; 63(5): 1083 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Greenwald, B. J. Mehrara, J. A. Spector, S. M. Warren, P. J. Fagenholz, L. P. Smith, P. J. Bouletreau, F. E. Crisera, H. Ueno, and M. T. Longaker In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate Am. J. Pathol., February 1, 2001; 158(2): 441 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Spector, B. J. Mehrara, J. A. Greenwald, P. B. Saadeh, D. S. Steinbrech, P. J. Bouletreau, L. P. Smith, and M. T. Longaker Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment Am J Physiol Cell Physiol, January 1, 2001; 280(1): C72 - C80. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Steinbrech, B. J. Mehrara, P. B. Saadeh, J. A. Greenwald, J. A. Spector, G. K. Gittes, and M. T. Longaker VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism Am J Physiol Cell Physiol, April 1, 2000; 278(4): C853 - C860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minami, R. D. Rosenberg, and W. C. Aird Transforming Growth Factor-beta 1-mediated Inhibition of the flk-1/KDR Gene Is Mediated by a 5'-Untranslated Region Palindromic GATA Site J. Biol. Chem., February 9, 2001; 276(7): 5395 - 5402. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |